We are stronger when we are all protected against respiratory diseases,” said Dr. Tomas Aragon, public health officer for ...

GSK plc (NYSE:GSK) released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, ...

reactogenicity and safety of Arexvy (Respiratory Syncytial Virus Vaccine) when co-administered with Shingrix (Zoster Vaccine). Shingrix is approved to prevent shingles (herpes zoster) in adults ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

Arexvy is approved for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus ... GSK Halts Herpes Simplex Virus Vaccine Development, Clears Path For ...

British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...

As the 2024-2025 respiratory virus season gets under way, statewide infectious disease experts urge everyone in Oregon to ...

An Ohio State University survey found that many adults are hesitant about getting flu, COVID-19, pneumococcal and respiratory ...

The new, free vaccine, Beyfortus, will be available to children up to 24 months old through their health care provider or at ...

The California Department of Public Health is encouraging all Californians to get vaccinated this season to protect ...